Publication date: Apr 16, 2025
Fernandez reports serving as a consultant and advisory board member AbbVie. Okun has no relevant disclosures.
| Concepts | Keywords |
|---|---|
| Armamentarium | Ci |
| Florida | Compared |
| Kansas | Control |
| Parkinson | Disorders |
| Tempo | Dopamine |
| Dose | |
| Drug | |
| Impulse | |
| Mds | |
| Motor | |
| Placebo | |
| Similar | |
| Tavapadon | |
| Tempo | |
| Updrs |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Parkinson’s Disease |
| drug | DRUGBANK | Dopamine |
| disease | MESH | impulse control disorders |
| drug | DRUGBANK | Levodopa |
| drug | DRUGBANK | Tropicamide |
| disease | MESH | Movement Disorder |
| disease | MESH | excessive daytime sleepiness |
| pathway | REACTOME | Dopamine receptors |
| disease | MESH | Sleepiness |
Original Article
(Visited 1 times, 1 visits today)